Probiotic Duo for Childhood Diarrhea
ثنائي البروبيوتيك لإسهال الأطفال
Journal: Frontiers in microbiology
University: Not specified in abstract
Study Type: RCT
Evidence Level: preliminary
Published:
⚠️ Warning: This is a preliminary study (animal/cell) and has not been proven in humans.
30-Second Summary
This randomized controlled trial investigates whether a combination of two specific probiotic strains can help children with acute infectious diarrhea by shortening its duration and influencing their gut microbiota.
1-Minute Summary
This prospective, randomized, controlled, open-label trial aims to evaluate the impact of a specific probiotic combination (Lactobacillus acidophilus DSMZ 26280 and Limosilactobacillus reuteri DSMZ 25441) on children aged 1-6 years experiencing acute infectious diarrhea. Researchers will assess if this probiotic intervention, given for 5 days alongside standard therapy, can reduce the duration of diarrhea and alter the composition of the gut microbiota. The study acknowledges previous suggestions for probiotics in diarrhea management but seeks to define strain-specific effects and microbiome correlations more clearly.
3-Minute Summary
This randomized, controlled, open-label trial investigates the impact of a specific probiotic combination (Lactobacillus acidophilus DSMZ 26280 and Limosilactobacillus reuteri DSMZ 25441) on acute infectious diarrhea in children aged 1-6 years. The study, conducted at a pediatric emergency department, aims to determine if this probiotic intervention, alongside standard therapy (oral rehydration ± intravenous fluids), can shorten the duration of diarrhea. Furthermore, it will explore how these probiotics influence the gut microbiota composition in the participating children. This research seeks to provide strain-specific insights into probiotic efficacy and their potential role in modulating the gut microbiome during acute diarrheal episodes.
Full Analysis
This prospective, randomized, controlled, open-label trial is designed to assess the efficacy of a specific probiotic combination (Lactobacillus acidophilus DSMZ 26280 and Limosilactobacillus reuteri DSMZ 25441) in children experiencing acute infectious diarrhea. The primary objective is to evaluate whether the 5-day probiotic intervention, when added to standard therapy (oral rehydration ± intravenous fluids), can reduce the duration of diarrheal illness. A key secondary objective involves analyzing the impact of these probiotics on the gut microbiota composition, providing valuable insights into the mechanisms by which they may exert their effects. By focusing on specific strains and their influence on the microbiome, the study aims to contribute to a more nuanced understanding of probiotic applications in pediatric acute infectious diarrhea. The 1:1 allocation to intervention or control group, coupled with a 24-hour symptom onset criterion for inclusion, suggests a well-controlled design to minimize confounding factors. The open-label nature, however, means that participants and researchers will be aware of the treatment assignment, which could potentially introduce some bias, although the primary outcome of diarrhea duration is relatively objective.Health Implications
While this study is ongoing, previous research suggests that certain probiotics may support gut health and potentially shorten the duration of acute infectious diarrhea. Incorporating a diet rich in fiber and diverse plant-based foods can foster a healthy gut microbiome, which may contribute to resilience against infections. Adequate hydration, often achieved through oral rehydration solutions during diarrheal episodes, remains crucial. This research may offer insights into specific probiotic strains that could complement these foundational healthy habits in managing acute diarrhea in children.
Key Findings
- The study aims to investigate the effect of a specific probiotic combination on the duration of acute infectious diarrhea in children.
- It will also examine the impact of these probiotics on the gut microbiota composition in the study participants.
- The research is a randomized, controlled, open-label trial conducted in a pediatric emergency department.